 , Adrenergic Agents , Adrenergic alpha-1 Receptor Antagonists , Adrenergic alpha-Antagonists , Adrenergic Antagonists , Agents producing tachycardia , Agents that produce hypertension , Agents that produce neuromuscular block (indirect) , Agents that reduce seizure threshold , Alkaloids , Anti-Infective Agents , Antiarrhythmic agents , Antiarrhythmics, Class I , Antiarrhythmics, Class Ia , Anticholinergic Agents , Antimalarials , Antiparasitic Agents , Antiprotozoals , Biological Products , Biopolymers , BSEP/ABCB11 Inhibitors , Carbohydrates , Cardiac Therapy , Cardiovascular Agents , Cholinergic Agents , Cinchona Alkaloids , Complex Mixtures , Compounds used in a research, industrial, or household setting , Cytochrome P-450 CYP1A2 Inhibitors , Cytochrome P-450 CYP1A2 Inhibitors (strong) , Cytochrome P-450 CYP2B6 Inhibitors , Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) , Cytochrome P-450 CYP2C8 Inducers , Cytochrome P-450 CYP2C8 Inducers (weak) , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C8 Inhibitors (weak) , Cytochrome P-450 CYP2C9 Inhibitors , Cytochrome P-450 CYP2C9 Inhibitors (moderate) , Cytochrome P-450 CYP2C9 Substrates , Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2D6 Inhibitors , Cytochrome P-450 CYP2D6 Inhibitors (strong) , Cytochrome P-450 CYP2E1 Substrates , Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (weak) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A7 Substrates , Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Drugs causing inadvertant photosensitivity , Drugs that are Mainly Renally Excreted , Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index , Enzyme Inhibitors , Heterocyclic Compounds, Fused-Ring , Highest Risk QTc-Prolonging Agents , Macromolecular Substances , Membrane Transport Modulators , Muscarinic Antagonists , Narrow Therapeutic Index Drugs , Neurotransmitter Agents , OAT3/SLC22A8 Inhibitors , OATP1B1/SLCO1B1 Inhibitors , OCT1 inhibitors , OCT2 Inhibitors , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Pharmaceutical Preparations , Photosensitizing Agents , Plant Extracts , Plant Preparations , Polymers , Polysaccharides , QTc Prolonging Agents , Quinolines , Quinuclidines , Sodium Channel Blockers , Voltage-Gated Sodium Channel Blockers